甲状旁腺癌临床诊断与管理
Clinical Diagnosis and Management of Parathyroid Carcinoma
DOI: 10.12677/acm.2026.162377, PDF,   
作者: 刘志灵:赣南医科大学第一临床医学院,江西 赣州;刘家锋*:赣南医科大学第一附属医院甲状腺疝外科,江西 赣州
关键词: 甲状旁腺癌诊断治疗外科手术Parathyroid Carcinoma Diagnosis Treatment Surgery
摘要: 甲状旁腺癌是罕见的恶性肿瘤,它的临床表现是甲状旁腺素升高、高钙血症以及全身各个系统的相关症状,它的罕见性,加上其多样化的临床表现,使其诊断特别具有挑战性。近年来随着医疗水平的不断提高,甲状旁腺癌的发现也相对增多,在临床上诊断甲状旁腺癌时应从临床表现、实验室检查、影像学检查、和病理学检查多个方面考虑,早期诊断、早期治疗可以有效改善患者预后。治疗以外科手术治疗为主,手术的彻底性可以有效降低肿瘤的复发。本文旨在对甲状旁腺癌进行一个综述,提高临床医生对甲状旁腺癌的认识,避免漏诊、误诊带来的不良后果。
Abstract: Parathyroid carcinoma is a rare malignant tumor whose clinical manifestations include elevated parathyroid hormone levels, hypercalcemia, and systemic symptoms affecting various organs. Its rarity, coupled with its diverse clinical presentation, renders diagnosis particularly challenging. In recent years, with continuous advances in medical standards, the detection rate of parathyroid carcinoma has relatively increased. Clinically, diagnosis should consider multiple aspects including clinical presentation, laboratory tests, imaging studies, and pathological examination. Early diagnosis and treatment can significantly improve patient prognosis. Surgical intervention remains the primary treatment modality, with thoroughness of resection effectively reducing tumor recurrence. This article aims to provide a comprehensive review of parathyroid carcinoma, enhancing clinicians’ awareness of this condition and thereby preventing the adverse consequences of misdiagnosis or missed diagnosis.
文章引用:刘志灵, 刘家锋. 甲状旁腺癌临床诊断与管理[J]. 临床医学进展, 2026, 16(2): 180-186. https://doi.org/10.12677/acm.2026.162377

参考文献

[1] Betea, D., Potorac, I. and Beckers, A. (2015) Parathyroid Carcinoma: Challenges in Diagnosis and Treatment. Annales dEndocrinologie, 76, 169-177. [Google Scholar] [CrossRef] [PubMed]
[2] Kassahun, W.T. and Jonas, S. (2011) Focus on Parathyroid Carcinoma. International Journal of Surgery, 9, 13-19. [Google Scholar] [CrossRef] [PubMed]
[3] Villar-del-Moral, J., Jiménez-García, A., Salvador-Egea, P., Martos-Martínez, J.M., Nuño-Vázquez-Garza, J.M., Serradilla-Martín, M., et al. (2014) Prognostic Factors and Staging Systems in Parathyroid Cancer: A Multicenter Cohort Study. Surgery, 156, 1132-1144. [Google Scholar] [CrossRef] [PubMed]
[4] Al-Kurd, A., Mekel, M. and Mazeh, H. (2014) Parathyroid carcinoma. Surgical Oncology, 23, 107-114. [Google Scholar] [CrossRef] [PubMed]
[5] 王培松, 薛帅, 王硕, 等. 中国甲状旁腺癌234例分析[J]. 中华内分泌外科杂志, 2017, 11(4): 334-337.
[6] Song, A., Yang, Y., Liu, S., Nie, M., Jiang, Y., Li, M., et al. (2020) Prevalence of Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in 153 Patients with Multiple Endocrine Neoplasia Type 1: Case Series and Literature Review. Frontiers in Endocrinology, 11, Article ID: 557050. [Google Scholar] [CrossRef] [PubMed]
[7] Torresan, F. and Iacobone, M. (2019) Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature. International Journal of Endocrinology, 2019, Article ID: 1761030. [Google Scholar] [CrossRef] [PubMed]
[8] Cetani, F., Pardi, E. and Marcocci, C. (2016) Update on Parathyroid Carcinoma. Journal of Endocrinological Investigation, 39, 595-606. [Google Scholar] [CrossRef] [PubMed]
[9] Erickson, L.A. and Mete, O. (2018) Immunohistochemistry in Diagnostic Parathyroid Pathology. Endocrine Pathology, 29, 113-129. [Google Scholar] [CrossRef] [PubMed]
[10] Yu, W., McPherson, J.R., Stevenson, M., van Eijk, R., Heng, H.L., Newey, P., et al. (2015) Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal Novel prune2 Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated with Cell Migration and Invasion. The Journal of Clinical Endocrinology & Metabolism, 100, E360-E364. [Google Scholar] [CrossRef] [PubMed]
[11] 王雪薇, 王培松, 陈光. 甲状旁腺癌诊治[J]. 外科理论与实践, 2018, 23(2): 112-115.
[12] Givi, B. and Shah, J.P. (2010) Parathyroid Carcinoma. Clinical Oncology, 22, 498-507. [Google Scholar] [CrossRef] [PubMed]
[13] Mignini, I., Pizzoferrato, M., Larosa, L., et al. (2021) Acute Pancreatitis and Parathyroid Carcinoma: A Case Report and Literature Review. European Review for Medical and Pharmacological Sciences, 25, 5972-5977.
[14] Shane, E. (2001) Parathyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 86, 485-493. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, J.H., Chung, S.M. and Kim, H.S. (2013) Osteitis Fibrosa Cystica Mistaken for Malignant Disease. Clinical and Experimental Otorhinolaryngology, 6, 110-113. [Google Scholar] [CrossRef] [PubMed]
[16] Su, A.W., Chen, C., Huang, C., Chen, P.C., Chen, W. and Chen, T. (2010) Primary Hyperparathyroidism with Brown Tumor Mimicking Metastatic Bone Malignancy. Journal of the Chinese Medical Association, 73, 177-180. [Google Scholar] [CrossRef] [PubMed]
[17] Xu, W., Qu, Y., Shi, W., Ma, B., Jiang, H., Wang, Y., et al. (2019) Multiple Bone Brown Tumor Secondary to Primary Hyperparathyroidism: A Case Report and Literature Review. Gland Surgery, 8, 810-816. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, L., Han, D., Chen, W., Zhang, S., Wang, Z., Li, K., et al. (2015) Non-Functional Parathyroid Carcinoma: A Case Report and Review of the Literature. Cancer Biology & Therapy, 16, 1569-1576. [Google Scholar] [CrossRef] [PubMed]
[19] Giessler, G.A. and Beech, D.J. (2001) Nonfunctional Parathyroid Carcinoma. Journal of the National Medical Association, 93, 251-255.
[20] Zelano, L., Locantore, P., Rota, C.A., Policola, C., Corsello, A., Rossi, E.D., et al. (2022) Parathyroid Carcinoma All-In-One, a Rare Life-Threatening Case with Multiple Systemic Manifestations: Case Report and Review of the Literature. Frontiers in Endocrinology (Lausanne), 13, Article ID: 881225. [Google Scholar] [CrossRef] [PubMed]
[21] Bae, J.H., Choi, H.J., Lee, Y., Moon, M.K., Park, Y.J., Shin, C.S., et al. (2012) Preoperative Predictive Factors for Parathyroid Carcinoma in Patients with Primary Hyperparathyroidism. Journal of Korean Medical Science, 27, 890-895. [Google Scholar] [CrossRef] [PubMed]
[22] Machado, N.N. and Wilhelm, S.M. (2019) Parathyroid Cancer: A Review. Cancers, 11, Article No. 1676. [Google Scholar] [CrossRef] [PubMed]
[23] Christakis, I., Vu, T., Chuang, H.H., Fellman, B., Figueroa, A.M.S., Williams, M.D., et al. (2017) The Diagnostic Accuracy of Neck Ultrasound, 4D-Computed Tomographyand Sestamibi Imaging in Parathyroid Carcinoma. European Journal of Radiology, 95, 82-88. [Google Scholar] [CrossRef] [PubMed]
[24] Takumi, K., Fukukura, Y., Hakamada, H., Nagano, H., Kumagae, Y., Arima, H., et al. (2019) CT Features of Parathyroid Carcinomas: Comparison with Benign Parathyroid Lesions. Japanese Journal of Radiology, 37, 380-389. [Google Scholar] [CrossRef] [PubMed]
[25] Yildiz, S., Aralasmak, A., Yetis, H., Kilicarslan, R., Sharifov, R., Alkan, A., et al. (2019) MRI Findings and Utility of DWI in the Evaluation of Solid Parathyroid Lesions. La Radiologia Medica, 124, 360-367. [Google Scholar] [CrossRef] [PubMed]
[26] Evangelista, L., et al. (2011) FDG-PET/CT and Parathyroid Carcinoma: Review of Literature and Illustrative Case Series. World Journal of Clinical Oncology, 2, 348-354. [Google Scholar] [CrossRef] [PubMed]
[27] Kim, J., Horowitz, G., Hong, M., Orsini, M., Asa, S.L. and Higgins, K. (2017) The Dangers of Parathyroid Biopsy. Journal of OtolaryngologyHead & Neck Surgery, 46, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[28] Marcocci, C., Cetani, F., Rubin, M.R., Silverberg, S.J., Pinchera, A. and Bilezikian, J.P. (2008) Parathyroid Carcinoma. Journal of Bone and Mineral Research, 23, 1869-1880. [Google Scholar] [CrossRef] [PubMed]
[29] Schantz, A. and Castleman, B. (1973) Parathyroid Carcinoma. A Study of 70 Cases. Cancer, 31, 600-605. [Google Scholar] [CrossRef] [PubMed]
[30] Tan, M., Morrison, C., Wang, P., Yang, X., Haven, C.J., Zhang, C., et al. (2004) Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma. Clinical Cancer Research, 10, 6629-6637. [Google Scholar] [CrossRef] [PubMed]
[31] Ordóñez, N.G. (2014) Value of GATA3 Immunostaining in the Diagnosis of Parathyroid Tumors. Applied Immunohistochemistry & Molecular Morphology, 22, 756-761. [Google Scholar] [CrossRef] [PubMed]
[32] Takada, N., Hirokawa, M., Suzuki, A., Higuchi, M., Kuma, S. and Miyauchi, A. (2016) Diagnostic Value of GATA-3 in Cytological Identification of Parathyroid Tissues. Endocrine Journal, 63, 621-626. [Google Scholar] [CrossRef] [PubMed]
[33] Truran, P.P., Johnson, S.J., Bliss, R.D., Lennard, T.W.J. and Aspinall, S.R. (2014) Parafibromin, Galectin‐3, PGP9.5, Ki67, and Cyclin D1: Using an Immunohistochemical Panel to Aid in the Diagnosis of Parathyroid Cancer. World Journal of Surgery, 38, 2845-2854. [Google Scholar] [CrossRef] [PubMed]
[34] 陈海珍, 薛松, 陈曦, 等. 甲状旁腺癌的诊断和治疗(附30例报告) [J]. 中国实用外科杂志, 2014, 34(4): 324-328.
[35] Hsu, K., Sippel, R.S., Chen, H. and Schneider, D.F. (2014) Is Central Lymph Node Dissection Necessary for Parathyroid Carcinoma? Surgery, 156, 1336-1341. [Google Scholar] [CrossRef] [PubMed]
[36] Asare, E.A., Sturgeon, C., Winchester, D.J., Liu, L., Palis, B., Perrier, N.D., et al. (2015) Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Annals of Surgical Oncology, 22, 3990-3995. [Google Scholar] [CrossRef] [PubMed]
[37] Schaapveld, M., Jorna, F.H., Aben, K.K.H., Haak, H.R., Plukker, J.T.M. and Links, T.P. (2011) Incidence and Prognosis of Parathyroid Gland Carcinoma: A Population-Based Study in the Netherlands Estimating the Preoperative Diagnosis. The American Journal of Surgery, 202, 590-597. [Google Scholar] [CrossRef] [PubMed]
[38] Schulte, K.M., Talat, N., Galata, G., Gilbert, J., Miell, J., Hofbauer, L.C., et al. (2014) Oncologic Resection Achieving R0 Margins Improves Disease-Free Survival in Parathyroid Cancer. Annals of Surgical Oncology, 21, 1891-1897. [Google Scholar] [CrossRef] [PubMed]
[39] Sadler, C., Gow, K.W., Beierle, E.A., Doski, J.J., Langer, M., Nuchtern, J.G., et al. (2014) Parathyroid Carcinoma in More than 1000 Patients: A Population-Level Analysis. Surgery, 156, 1622-1630. [Google Scholar] [CrossRef] [PubMed]
[40] Xue, S., Chen, H., Lv, C., Shen, X., Ding, J., Liu, J., et al. (2016) Preoperative Diagnosis and Prognosis in 40 Parathyroid Carcinoma Patients. Clinical Endocrinology, 85, 29-36. [Google Scholar] [CrossRef] [PubMed]
[41] Kubal, M., Lech, M., Lajeunesse-Trempe, F., Drakou, E.E., Grossman, A.B. and Dimitriadis, G.K. (2024) Advances in the Management of Parathyroid Carcinoma. Molecular and Cellular Endocrinology, 592, Article ID: 112329. [Google Scholar] [CrossRef] [PubMed]
[42] Zagzag, J., Hu, M.I., Fisher, S.B. and Perrier, N.D. (2018) Hypercalcemia and Cancer: Differential Diagnosis and Treatment. CA: A Cancer Journal for Clinicians, 68, 377-386. [Google Scholar] [CrossRef] [PubMed]
[43] Takeuchi, Y., Takahashi, S., Miura, D., Katagiri, M., Nakashima, N., Ohishi, H., et al. (2016) Cinacalcet Hydrochloride Relieves Hypercalcemia in Japanese Patients with Parathyroid Cancer and Intractable Primary Hyperparathyroidism. Journal of Bone and Mineral Metabolism, 35, 616-622. [Google Scholar] [CrossRef] [PubMed]
[44] Fountas, A., Andrikoula, M., Giotaki, Z., Limniati, C., Tsakiridou, E., Tigas, S., et al. (2015) The Emerging Role of Denosumab in the Long-Term Management of Parathyroid Carcinoma-Related Refractory Hypercalcemia. Endocrine Practice, 21, 468-473. [Google Scholar] [CrossRef] [PubMed]
[45] Christakis, I., Silva, A.M., Williams, M.D., Garden, A., Grubbs, E.G., Busaidy, N.L., et al. (2017) Postoperative Local-Regional Radiation Therapy in the Treatment of Parathyroid Carcinoma: The MD Anderson Experience of 35 Years. Practical Radiation Oncology, 7, e463-e470. [Google Scholar] [CrossRef] [PubMed]
[46] Rozhinskaya, L., Pigarova, E., Sabanova, E., Mamedova, E., Voronkova, I., Krupinova, J., et al. (2017) Diagnosis and Treatment Challenges of Parathyroid Carcinoma in a 27-Year-Old Woman with Multiple Lung Metastases. Endocrinology, Diabetes & Metabolism Case Reports, 2017, 1-4. [Google Scholar] [CrossRef] [PubMed]
[47] Shaha, A.R. and Shah, J.P. (1999) Parathyroid Carcinoma: A Diagnostic and Therapeutic Challenge. Cancer, 86, 378-380. [Google Scholar] [CrossRef] [PubMed]
[48] Talat, N. and Schulte, K. (2010) Clinical Presentation, Staging and Long-Term Evolution of Parathyroid Cancer. Annals of Surgical Oncology, 17, 2156-2174. [Google Scholar] [CrossRef] [PubMed]
[49] Schulte, K. and Talat, N. (2012) Diagnosis and Management of Parathyroid Cancer. Nature Reviews Endocrinology, 8, 612-622. [Google Scholar] [CrossRef] [PubMed]
[50] Sawhney, S., Vaish, R., Jain, S., Mittal, N., Ankathi, S.K., Thiagarajan, S., et al. (2021) Parathyroid Carcinoma: A Review. Indian Journal of Surgical Oncology, 13, 133-142. [Google Scholar] [CrossRef] [PubMed]